Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Disease”

3,304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,304 results

Testing effectiveness (Phase 2)Study completedNCT01685203
What this trial is testing

Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
AbbVie (prior sponsor, Abbott) 316
Large-scale testing (Phase 3)Study completedNCT00039962
What this trial is testing

Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Who this might be right for
Hepatitis CHepatitis C, Chronic
SciClone Pharmaceuticals 500
Testing effectiveness (Phase 2)Ended earlyNCT01425970
What this trial is testing

Chronically-infected HCV Genotype 2 and 3 Treatment-naive Subjects: Part A: Safety and Efficacy of INX-08189 With Peg IFN Alfa-2a and Ribavirin. Part B: INX-08189 in Interferon Free Treatment With Daclatasvir and/or Ribavirin

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 210
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Not applicableUnknownNCT04136405
What this trial is testing

Cross Sectional Survey on the Burden, Impacts and Causes of Hepatitis C Virus (HCV) Outbreak in South West Region in Burkina Faso

Who this might be right for
Hepatitis C Virus Infection, Past or PresentChronic Hepatitis c
ANRS, Emerging Infectious Diseases 3,300
Testing effectiveness (Phase 2)Study completedNCT01508156
What this trial is testing

Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 130
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Large-scale testing (Phase 3)Study completedNCT00410202
What this trial is testing

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus

Who this might be right for
Hepatitis B, Chronic
Bristol-Myers Squibb 629
Post-approval studies (Phase 4)UnknownNCT01056172
What this trial is testing

PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Who this might be right for
Chronic Hepatitis C
Pusan National University Yangsan Hospital 164
Large-scale testing (Phase 3)Active Not RecruitingNCT03489239
What this trial is testing

Entecavir to TAF Switch

Who this might be right for
Hepatitis B
Thomas Jefferson University 27
Early research (Phase 1)Study completedNCT00782353
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection

Who this might be right for
Chronic Hepatitis C
Hoffmann-La Roche 35
Not applicableLooking for participantsNCT06387745
What this trial is testing

Referral of Patients to Hepatology With Hepatoscope

Who this might be right for
Chronic Liver Disease
University Hospital, Antwerp 200
Testing effectiveness (Phase 2)Study completedNCT03852433
What this trial is testing

Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)

Who this might be right for
Chronic Hepatitis Delta
Gilead Sciences 175
Not applicableStudy completedNCT02689245
What this trial is testing

Randomized Controlled Trial Comparing the Efficacy and Safety of FMT in Hepatitis B Reactivation Leads to Acute on Chronic Liver Failure.

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 64
Early research (Phase 1)Study completedNCT07110441
What this trial is testing

Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers

Who this might be right for
Acute-on-Chronic Liver Failure
Genfit 52
Post-approval studies (Phase 4)Not Yet RecruitingNCT06900166
What this trial is testing

Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg

Who this might be right for
Chronic Hepatitis B
Huashan Hospital 360
Large-scale testing (Phase 3)Study completedNCT00115245
What this trial is testing

Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Novartis
Testing effectiveness (Phase 2)Study completedNCT01013194
What this trial is testing

Human Fetal Liver Cell Transplantation in Chronic Liver Failure

Who this might be right for
Liver Cirrhosis
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies 25
Testing effectiveness (Phase 2)Looking for participantsNCT05771402
What this trial is testing

A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

Who this might be right for
Chronic Hepatitis bAnti-PD-1 AntibodyPeg-IFNα
The Second Affiliated Hospital of Chongqing Medical University 120
Testing effectiveness (Phase 2)Study completedNCT03020095
What this trial is testing

Efficacy and Safety of Ravidasvir + Danoprevir/r 12-week Oral Therapy in Treatment-Naive Non Cirrhotic G1 CHC Taiwan

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 38
Next Page